New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Overall cancer mortality continued to decline from 2019 to 2020

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America
Oncology December 19,2023
Overall cancer mortality continued to decline from 2019 to 2020

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America
Oncology December 19,2023
Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin
Oncology December 19,2023
Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin
Oncology December 19,2023
Innovative technology shows great promise against certain head and neck cancers

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea
Oncology December 19,2023
Innovative technology shows great promise against certain head and neck cancers

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea
Oncology December 19,2023
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPreliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small ce
World medicine December 19,2023
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPreliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small ce
World medicine December 19,2023
Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according
Oncology December 19,2023
Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according
Oncology December 19,2023
Ultrafine particles can change defense against lung cancer

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp
Oncology December 19,2023
Ultrafine particles can change defense against lung cancer

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp
Oncology December 19,2023
Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct
Oncology December 19,2023
Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct
Oncology December 19,2023
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun
Oncology December 19,2023
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun
Oncology December 19,2023
Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).
Oncology December 19,2023
Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).
Oncology December 19,2023
How gut bacteria can impact treatments for cancer

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M
Oncology December 19,2023
How gut bacteria can impact treatments for cancer

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M
Oncology December 19,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com